REVB
Revelation Biosciences Inc
NASDAQ: REVB · HEALTHCARE · BIOTECHNOLOGY
$1.12
-0.88% today
Updated 2026-05-01
Market cap
$4.32M
P/E ratio
—
P/S ratio
2.88x
EPS (TTM)
$-23.95
Dividend yield
—
52W range
$1 – $40
Volume
0.1M
Revelation Biosciences Inc (REVB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |